Janssen Biotech, Inc.

PA · United States · Reporting entity ID 100000000329

Total reported 2019–2025

$141.1M

#73 of 2,960 reporting companies — 0.2% of all reported industry payments

$127.1M in general payments across 1,540,685 records, plus $14.0M in research funding across 21 records.

How it breaks down

General payments $127,099,310

Research funding $14,013,484

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.